A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

Study Identifier
M10-014
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Pain
  • Study Drug
  • ABT-894
  • placebo
  • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18 - 75 Years

    Protocol Summary

    The purpose of this study is to evaluate the safety and efficacy of a 6 mg twice a day dose of an investigational product in subjects with diabetic neuropathy

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 6614
    Spring Valley, California, United States, 91978
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 6617
    Walnut Creek, California, United States, 94598
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 6356
    Hollywood, Florida, United States, 33021
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 6615
    Tampa, Florida, United States, 33603
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 6358
    Wellington, Florida, United States, 33414
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 6609
    St Louis, Missouri, United States, 63141
    Status
    Not applicable
    Showing {first} - {last} of {total} Results